Health organizations in Europe and the U.S. are pushing ahead with plans to compile massive databases of patient information, which they anticipate will not just improve treatments and survival chances for cancer sufferers, but will drive the development of new therapies. These moves will involve many more participants in massive clinical trials than today, and will allow medical centers in the developed world to expand their reach globally.
One organization, the American Society of Clinical Oncology (ASCO), aims to have ready by 2015 the production version of its CancerLinQ 'learning health system,' building on the experience of a 170,000-record prototype unveiled in 2013. At a White House event in November 2013, Thomas Kalil, deputy director for technology and innovation at the White House Office of Science and Technology Policy, identified CancerLinQ as one of a number of healthcare systems that would aggregate large quantities of data to improve treatment.
No entries found
Log in to Read the Full Article
Sign In
Sign in using your ACM Web Account username and password to access premium content if you are an ACM member, Communications subscriber or Digital Library subscriber.
Need Access?
Please select one of the options below for access to premium content and features.
Create a Web Account
If you are already an ACM member, Communications subscriber, or Digital Library subscriber, please set up a web account to access premium content on this site.
Join the ACM
Become a member to take full advantage of ACM's outstanding computing information resources, networking opportunities, and other benefits.
Subscribe to Communications of the ACM Magazine
Get full access to 50+ years of CACM content and receive the print version of the magazine monthly.
Purchase the Article
Non-members can purchase this article or a copy of the magazine in which it appears.